Inventor
BARBERIS ALCIDE
CH22 patents
⚠️ This page may combine multiple inventors who share the name “BARBERIS ALCIDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ESBATECH ALCON BIOMED RES UNIT
6 patentsUS9683034B2Jun 20, 2017
Stable and soluble antibodies inhibiting TNFα
ESBATECH ALCON BIOMED RES UNIT2 citations72
US10125186B2Nov 13, 2018
Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
ESBATECH ALCON BIOMED RES UNIT0 citations51
US8691228B2Apr 8, 2014
Stable and soluble antibodies inhibiting TNFα
ESBATECH ALCON BIOMED RES UNIT0 citations51
US10570190B2Feb 25, 2020
Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
ESBATECH ALCON BIOMED RES UNIT0 citations50
US9518108B2Dec 13, 2016
Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
ESBATECH ALCON BIOMED RES UNIT0 citations50
US9315572B2Apr 19, 2016
Stable and soluble antibodies inhibiting TNF alpha
ESBATECH ALCON BIOMED RES UNIT0 citations50
ESBATECH AG
3 patentsUS7258986B2Aug 21, 2007
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
ESBATECH AG24 citations89
US7258985B2Aug 21, 2007
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
ESBATECH AG14 citations80
US7566528B2Jul 28, 2009
Method for the identification and/or validation of receptor tyrosine kinase inhibitors
ESBATECH AG2 citations55